Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats

AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms. METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2006-05, Vol.12 (18), p.2908-2913
Hauptverfasser: Wang, Ya-Jun, Sun, Jia-Bang, Li, Fei, Zhang, Shu-Wen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2913
container_issue 18
container_start_page 2908
container_title World journal of gastroenterology : WJG
container_volume 12
creator Wang, Ya-Jun
Sun, Jia-Bang
Li, Fei
Zhang, Shu-Wen
description AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms. METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot. RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05). CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.
doi_str_mv 10.3748/wjg.v12.i18.2908
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4087809</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>22003458</cqvip_id><wanfj_id>wjg200618016</wanfj_id><sourcerecordid>wjg200618016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</originalsourceid><addsrcrecordid>eNpVkc2P0zAQxS0EYsvCnROyENcUfySxc0FC1cIircQFzpbjjNvppk6wnVb73-OqFR-nObw3vzeaR8hbztZS1frjab9dH7lYI9dr0TH9jKyE4F0ldM2ekxVnTFWdFOqGvEppz5iQshEvyQ1vFdeaqxVZ7p9miCPOOMABLcWQIST0CIk6iMsIGCoMw-JgoNYtGehsg4tgM2ZM1KY0ObS5qCfMu2LJeCzaFOjk6RynXAD0EYNNQDcFT6PN6TV54e2Y4M113pKfX-5-bO6rh-9fv20-P1SubliuWuWh6Tvo-2HgduC8E71wFqB3tZXM175TanANWG1b7j1w2QnVa5CuaRrt5S35dOHOS3-AwUHI0Y5mjniw8clMFs3_SsCd2U5HUzOtNOsK4MMFcLLB27A1-2mJoZxsyusFYy3XjLfFxi42F6eUIvg_EZyZc1NnuylNmdKUOTdVVt79e9rfhWs1xfD-ytxNYfsLS3hv3aPHEYwo0bJutPwNTvag_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Ya-Jun ; Sun, Jia-Bang ; Li, Fei ; Zhang, Shu-Wen</creator><creatorcontrib>Wang, Ya-Jun ; Sun, Jia-Bang ; Li, Fei ; Zhang, Shu-Wen</creatorcontrib><description>AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms. METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot. RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05). CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v12.i18.2908</identifier><identifier>PMID: 16718817</identifier><language>eng</language><publisher>United States: Department of General Surgery, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China</publisher><subject>Acute Disease ; Amylases - blood ; Animals ; Apoptosis - drug effects ; Apoptosis - physiology ; Ascites - pathology ; Basic Research ; Ceruletide - adverse effects ; Ceruletide - pharmacology ; Enzyme Activation - drug effects ; Enzyme Activation - physiology ; Hyperlipidemias - blood ; Hyperlipidemias - physiopathology ; In Situ Nick-End Labeling ; Lipids - blood ; Male ; Organ Size - drug effects ; Organ Size - physiology ; Pancreas - drug effects ; Pancreas - enzymology ; Pancreas - pathology ; Pancreatitis - chemically induced ; Pancreatitis - pathology ; Pancreatitis - physiopathology ; Polyethylene Glycols - adverse effects ; Protein Kinase C - physiology ; Rats ; Rats, Sprague-Dawley ; 胰腺炎 ; 蛋白质 ; 蛙皮缩胆囊肽 ; 高血脂</subject><ispartof>World journal of gastroenterology : WJG, 2006-05, Vol.12 (18), p.2908-2913</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2006 Baishideng Publishing Group Co., Limited. All rights reserved. 2006</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</citedby><cites>FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087809/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087809/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16718817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Ya-Jun</creatorcontrib><creatorcontrib>Sun, Jia-Bang</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Zhang, Shu-Wen</creatorcontrib><title>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms. METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot. RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05). CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.</description><subject>Acute Disease</subject><subject>Amylases - blood</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - physiology</subject><subject>Ascites - pathology</subject><subject>Basic Research</subject><subject>Ceruletide - adverse effects</subject><subject>Ceruletide - pharmacology</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Activation - physiology</subject><subject>Hyperlipidemias - blood</subject><subject>Hyperlipidemias - physiopathology</subject><subject>In Situ Nick-End Labeling</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Organ Size - drug effects</subject><subject>Organ Size - physiology</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - enzymology</subject><subject>Pancreas - pathology</subject><subject>Pancreatitis - chemically induced</subject><subject>Pancreatitis - pathology</subject><subject>Pancreatitis - physiopathology</subject><subject>Polyethylene Glycols - adverse effects</subject><subject>Protein Kinase C - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>胰腺炎</subject><subject>蛋白质</subject><subject>蛙皮缩胆囊肽</subject><subject>高血脂</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc2P0zAQxS0EYsvCnROyENcUfySxc0FC1cIircQFzpbjjNvppk6wnVb73-OqFR-nObw3vzeaR8hbztZS1frjab9dH7lYI9dr0TH9jKyE4F0ldM2ekxVnTFWdFOqGvEppz5iQshEvyQ1vFdeaqxVZ7p9miCPOOMABLcWQIST0CIk6iMsIGCoMw-JgoNYtGehsg4tgM2ZM1KY0ObS5qCfMu2LJeCzaFOjk6RynXAD0EYNNQDcFT6PN6TV54e2Y4M113pKfX-5-bO6rh-9fv20-P1SubliuWuWh6Tvo-2HgduC8E71wFqB3tZXM175TanANWG1b7j1w2QnVa5CuaRrt5S35dOHOS3-AwUHI0Y5mjniw8clMFs3_SsCd2U5HUzOtNOsK4MMFcLLB27A1-2mJoZxsyusFYy3XjLfFxi42F6eUIvg_EZyZc1NnuylNmdKUOTdVVt79e9rfhWs1xfD-ytxNYfsLS3hv3aPHEYwo0bJutPwNTvag_A</recordid><startdate>20060514</startdate><enddate>20060514</enddate><creator>Wang, Ya-Jun</creator><creator>Sun, Jia-Bang</creator><creator>Li, Fei</creator><creator>Zhang, Shu-Wen</creator><general>Department of General Surgery, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China</general><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20060514</creationdate><title>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</title><author>Wang, Ya-Jun ; Sun, Jia-Bang ; Li, Fei ; Zhang, Shu-Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute Disease</topic><topic>Amylases - blood</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - physiology</topic><topic>Ascites - pathology</topic><topic>Basic Research</topic><topic>Ceruletide - adverse effects</topic><topic>Ceruletide - pharmacology</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Activation - physiology</topic><topic>Hyperlipidemias - blood</topic><topic>Hyperlipidemias - physiopathology</topic><topic>In Situ Nick-End Labeling</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Organ Size - drug effects</topic><topic>Organ Size - physiology</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - enzymology</topic><topic>Pancreas - pathology</topic><topic>Pancreatitis - chemically induced</topic><topic>Pancreatitis - pathology</topic><topic>Pancreatitis - physiopathology</topic><topic>Polyethylene Glycols - adverse effects</topic><topic>Protein Kinase C - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>胰腺炎</topic><topic>蛋白质</topic><topic>蛙皮缩胆囊肽</topic><topic>高血脂</topic><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ya-Jun</creatorcontrib><creatorcontrib>Sun, Jia-Bang</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Zhang, Shu-Wen</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ya-Jun</au><au>Sun, Jia-Bang</au><au>Li, Fei</au><au>Zhang, Shu-Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2006-05-14</date><risdate>2006</risdate><volume>12</volume><issue>18</issue><spage>2908</spage><epage>2913</epage><pages>2908-2913</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms. METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot. RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05). CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.</abstract><cop>United States</cop><pub>Department of General Surgery, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China</pub><pmid>16718817</pmid><doi>10.3748/wjg.v12.i18.2908</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2006-05, Vol.12 (18), p.2908-2913
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4087809
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Acute Disease
Amylases - blood
Animals
Apoptosis - drug effects
Apoptosis - physiology
Ascites - pathology
Basic Research
Ceruletide - adverse effects
Ceruletide - pharmacology
Enzyme Activation - drug effects
Enzyme Activation - physiology
Hyperlipidemias - blood
Hyperlipidemias - physiopathology
In Situ Nick-End Labeling
Lipids - blood
Male
Organ Size - drug effects
Organ Size - physiology
Pancreas - drug effects
Pancreas - enzymology
Pancreas - pathology
Pancreatitis - chemically induced
Pancreatitis - pathology
Pancreatitis - physiopathology
Polyethylene Glycols - adverse effects
Protein Kinase C - physiology
Rats
Rats, Sprague-Dawley
胰腺炎
蛋白质
蛙皮缩胆囊肽
高血脂
title Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A30%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperlipidemia%20intensifies%20cerulein-induced%20acute%20pancreatitis%20associated%20with%20activation%20of%20protein%20kinase%20C%20in%20rats&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Wang,%20Ya-Jun&rft.date=2006-05-14&rft.volume=12&rft.issue=18&rft.spage=2908&rft.epage=2913&rft.pages=2908-2913&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v12.i18.2908&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200618016%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16718817&rft_cqvip_id=22003458&rft_wanfj_id=wjg200618016&rfr_iscdi=true